

%201.webp)


%201.webp)




LSPedia 的全球序列化系列
序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
欢迎来到 LspEdia,在这里,创新与奉献精神相结合。
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。



%201.webp)


%201.webp)




序列化不是一刀切的。由于美国、欧盟、亚洲和中东的规定各不相同,公司必须应对复杂的要求网络。您为全球合规做好准备了吗?
.avif)
如果你热衷于有所作为并在协作环境中茁壮成长,LspEdia 就是你的不二之选。

Pharmaceutical products in Malaysia are regulated by the National Pharmaceutical Regulatory Agency (NPRA) under the Ministry of Health Malaysia. Malaysia has implemented a national pharmaceutical verification and traceability initiative to improve supply chain transparency and prevent counterfeit medicines.
Malaysia operates the Pharmaceutical Track and Trace System (Pharma T&T), which requires pharmaceutical products to carry GS1 compliant DataMatrix barcodes with serialized identifiers. The system enables tracking and verification of medicines throughout the pharmaceutical supply chain.
The Pharma T&T framework supports digital reporting of medicine movement from manufacturers and importers through distributors to pharmacies. The system aims to improve regulatory oversight, protect patients from falsified medicines, and strengthen the integrity of the pharmaceutical supply chain.
Implementation has been phased, with serialization requirements initially applied to selected pharmaceutical products and progressively expanded.
Pharmaceutical products distributed in Malaysia must include a 2D DataMatrix barcode applied to the secondary packaging.
The DataMatrix must comply with GS1 standards and typically contains the following data elements:
These identifiers allow each medicine pack to be uniquely identified and verified through the national traceability system.
Human readable information printed on the packaging must correspond to the encoded barcode data.
2017–2018
Malaysia began developing a national pharmaceutical traceability strategy to strengthen medicine supply chain monitoring.
2019 onward
The Pharmaceutical Track and Trace System (Pharma T&T) was introduced to support serialization and digital verification of medicines.
Current Status
Serialization and traceability requirements are being implemented in phases across the pharmaceutical supply chain.
Supply chain participants must ensure accurate reporting of serialization data to maintain traceability.
Traceability reporting in Malaysia is managed through the Pharmaceutical Track and Trace System (Pharma T&T) operated by the Ministry of Health through the National Pharmaceutical Regulatory Agency.
The system enables supply chain participants to report serialization data and product movement through electronic interfaces and APIs.
Participants interacting with the system include:
The platform supports:
Malaysia’s pharmaceutical traceability system focuses primarily on unit level serialization using DataMatrix barcodes.
Aggregation at case or pallet level is not explicitly mandated in publicly available regulatory guidance. Pharmaceutical companies may implement aggregation internally to support warehouse automation and logistics operations.
We invite you to learn more about how LSPedia can support your compliance and supply chain needs. For more information about our solutions, partnership opportunities, or to speak with one of our experts.